Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Bio-Techne To Host Conference Call On October 31, 2016 To Announce First Quarter Financial Results

Bio-Techne Corporation
Posted on: 17 Oct 16

PR Newswire

MINNEAPOLIS, Oct. 17, 2016

MINNEAPOLIS, Oct. 17, 2016 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Monday, October 31, 2016, at 8:00 a.m. CDT to review first quarter fiscal 2017 financial results.

Access to the discussion may be obtained as follows:

Time:    

 8:00 a.m. CDT

Date:   

 October 31, 2016

Dial-in:  

 1-888-438-5448 or 1-719-457-2714 (for international callers)

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by going to:

http://audio.viavid.com/20161031-121376-bio-techne.mp3

The replay will be available from 11:00 a.m. CDT on Monday, October 31, 2016 until 11:00 p.m. CST on Wednesday, November 30, 2016.

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins––notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds --- which are sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotech Division, headquartered in Minneapolis, Minnesota.  The Protein Platform Division manufactures innovative protein analysis tools under the ProteinSimple brand name that greatly automate western blotting and immunoassay practices. The Diagnostics Division manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls for OEM customer and clinical customers. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $499 million in net sales in fiscal 2016 and has approximately 1,700 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio-techne.com.

Logo - http://photos.prnewswire.com/prnh/20160503/363268LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-october-31-2016-to-announce-first-quarter-financial-results-300345897.html

SOURCE Bio-Techne Corporation

PR Newswire
www.prnewswire.com

Last updated on: 17/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.